Inventor · disambiguated record
Johannes Lengler
Also filed as: LENGLER JOHANNES
6 granted patents·4 pending applications·10 citations·filing 2016–2023
75Inventor score
Top patents by PatentIndex Score
10 records- 0192US10189888B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ABAXALTA INC·Filed 2016·Granted Jan 29, 2019·6 cites·38 claims
- 0285US10842853B2Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia BBAXALTA INC·Filed 2018·Granted Nov 24, 2020·2 cites·25 claims
- 0376US10189889B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ABAXALTA INC·Filed 2016·Granted Jan 29, 2019·2 cites·10 claims
- 0474US2022213172A1Viral vectors encoding recombinant fviii variants with increased expression for gene therapy of hemophilia aTAKEDA PHARMACEUTICALS CO·Filed 2022·Application pending·0 cites
- 0573US11254731B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ATAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Feb 22, 2022·0 cites·10 claims
- 0670US11492388B2Viral vectors encoding recombinant FVIII variants with increased expression for gene therapy of hemophilia ATAKEDA PHARMACEUTICALS CO·Filed 2018·Granted Nov 8, 2022·0 cites·19 claims
- 0770US2024100128A1Gene therapy of hemophilia b using viral vectors encoding recombinant fix variants with increased expressionTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0863US11596671B2Gene therapy of hemophilia B using viral vectors encoding recombinant fix variants with increased expressionTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Mar 7, 2023·0 cites·16 claims
- 0962US2021128700A1Viral vectors encoding recombinant fix with increased expression for gene therapy of hemophilia bBAXALTA INC·Filed 2020·Application pending·0 cites
- 1048US2023043051A1Adeno-associated virus vectors based gene therapy for hereditary angioedemaSHIRE HUMAN GENETIC THERAPIES·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →